You can purchase shares of NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB:AURX) through any online brokerage.
There are no as such competitors for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..
NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. has a consensus price target of $3.00.
The stock price for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB: AURX) is $1.09 last updated November 11, 2026 at 11:18 AM EST.
There are no upcoming dividends for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..
NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..
NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.
Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chronic wound care. The company operates as a single segment focused on regenerative therapies that utilize autologous...